WEILAND JOHN H 4
4 · Solventum Corp · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Solventum (SOLV) Director John H. Weiland Converts 3,403 RSUs
What Happened John H. Weiland, a director of Solventum Corp (SOLV), converted (exercised) 3,403 derivative units into 3,403 shares on April 30, 2026. The filing reports an acquisition of 3,403 shares at $0.00 per share (total reported value $0) and a corresponding disposition of 3,403 derivative securities (the RSUs) as part of the conversion. This was not a cash purchase or sale of stock; it reflects settlement of vested equity awards.
Key Details
- Transaction date: 2026-04-30; Filing date: 2026-05-01 (filed timely).
- Reported price: $0.00 per share; reported aggregate value: $0.
- Shares issued/received: 3,403 common shares via conversion of RSUs.
- Shares disposed (derivative): 3,403 RSU units were converted/terminated.
- Footnotes: F1 — Each RSU converts to 1 share on settlement. F2 — The RSUs were fully vested.
- Shares owned after the transaction: not specified in the provided filing.
Context
- The transaction code M indicates an exercise or conversion of a derivative (here, RSUs converting into common stock). Because the RSUs were fully vested and converted, this is a routine settlement of equity compensation rather than an open-market purchase or sale. It does not by itself indicate buying or selling intent.
Insider Transaction Report
Form 4
Solventum CorpSOLV
WEILAND JOHN H
Director
Transactions
- Exercise/Conversion
Common Stock
2026-04-30+3,403→ 8,947 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-04-30−3,403→ 0 totalExp: 2035-04-30→ Common Stock (3,403 underlying)
Footnotes (2)
- [F1]Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- [F2]The RSUs are fully vested.
Signature
/s/Megan Bombick, attorney-in-fact for John H. Weiland|2026-05-01